How AI Is Aiming at the Bad Math of Drug Development

Robert Marcus
Nov 29, 2021

Related news

Oct 4
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

The Coming Age for Tech x Bio: The “Industrial Bio Complex”

Jan 7
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

Alphabet's VC Arm adds Senior Healthcare Partner

Feb 18
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Investors love data. So why not dig into sustainability metrics?

Nov 5
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Is AI delivering on the hype?

Sep 9
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Gates Foundation pours cash into British firm Exscientia to fight pandemics

Feb 21
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

Intelligence Artificielle : l'UM6P signe un partenariat avec la start-up ALPHA10X

Dec 2
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

VC investors share AI's impact on LS industries

Nov 23
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

AI Software Market Set to Reach New Heights Next Year

Sep 28
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Vietnam Accelerates Investment in Artificial Intelligence

Feb 21
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

Morocco’s Mohammed VI Polytechnic University and ALPHA10X Sign Research and Development Partnership Agreement

Feb 21
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

Innovative AI-powered Search and Discovery Platform; Interview With Robert Marcus

Mar 2
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

ALPHA10X : de l’IA pour réduire le risque lié à l’investissement dans les sciences de la vie